NRX Pharmaceuticals- Warrants (24/05/2026) Receivables

As of the most recent data (March 2026), NRXPW shows a receivables of $180K. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRXPW's receivables is now $180K (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether NRX Pharmaceuticals- Warrants (24/05/2026) is outperforming or lagging.

Tracking NRXPW's receivables over time shows whether NRX Pharmaceuticals- Warrants (24/05/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $180K In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has NRX Pharmaceuticals- Warrants (24/05/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $180K) with ownership activity and broader fundamentals.

NRX Pharmaceuticals- Warrants (24/05/2026)'s receivables is $180K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.